Showing results (2241-2250 of 2,381) with videos related to
Sort By:
Pageof 239
STAR Protocols|November 3, 2024
Protocol for mapping differential protein-protein interaction networks using affinity purification-mass spectrometryPrashant Kaushal, Manisha R Ummadi, Gwendolyn M Jang, et al.Frontiers in Pharmacology|July 3, 2015
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer modelsS Lindsey Davis, Kelli M Robertson, Todd M Pitts, et al.BMC Microbiology|July 10, 2026
Plasmids of co-circulating Staphylococcus aureus serve as vehicles for antimicrobial resistance sharing across diseased host-species at short timescalesKathryn R Piper, Ana Beatriz Garcez Buiatte, Stephanie S R Souza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 9, 2008
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancersAlex A Adjei, Roger B Cohen, Wilbur Franklin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2Jennifer L Spratlin, Roger B Cohen, Matthew Eadens, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeksM L Rothenberg, J G Kuhn, L J Schaaf, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapyLeonard B Saltz, Lee S Rosen, John L Marshall, et al.Critical Care Explorations|January 24, 2022
VE-CAM-S: Visual EEG-Based Grading of Delirium Severity and Associations With Clinical OutcomesRyan A Tesh, Haoqi Sun, Jin Jing, et al.Lancet (London, England)|July 14, 2023
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trialJürgen C Becker, Selma Ugurel, Ulrike Leiter, et al.Thorax|July 20, 2024
Non-cigarette tobacco products, aryl-hydrocarbon receptor repressor gene methylation and smoking-related health outcomesChristina M Eckhardt, Pallavi Balte, Jack E Morris, et al.Pageof 239